Ovarian suppression induced with Buserelin or danazol in the management of endometriosis: a randomized, comparative study. 1989

W P Dmowski, and E Radwanska, and Z Binor, and I Tummon, and P Pepping
Department of Obstetrics and Gynecology, Rush Medical College, Chicago, Illinois 60614.

The effectiveness of Buserelin (Hoechst-Roussel Pharmaceuticals, Inc., Somerville, NJ) (0.2 mg subcutaneously [SC] or 1.2 mg intranasally [IN] per day) and danazol (800 mg per day) in inducing ovarian suppression for the management of endometriosis was compared in a prospective randomized study. During 6 months of treatment, peripheral follicle-stimulating hormone (FSH), luteinizing hormone (LH), and estradiol concentrations were suppressed to a similar degree in both groups. Symptomatic improvement and laparoscopically assessed regression of endometriotic lesions also were comparable. After treatment, 8 of 18 infertile women treated with Buserelin and 5 of 8 treated with danazol conceived. General and hypoestrogenic side effects were similar in both groups, while androgenic and anabolic were more frequent with danazol. High density lipoprotein (HDL)-cholesterol increased in the Buserelin and decreased in the danazol group. The study indicates that at the dose tested, buserelin and danazol induce a similar degree of ovarian suppression resulting in a comparable clinical improvement and regression of endometriotic lesions.

UI MeSH Term Description Entries
D008598 Menstruation The periodic shedding of the ENDOMETRIUM and associated menstrual bleeding in the MENSTRUAL CYCLE of humans and primates. Menstruation is due to the decline in circulating PROGESTERONE, and occurs at the late LUTEAL PHASE when LUTEOLYSIS of the CORPUS LUTEUM takes place.
D010053 Ovary The reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE. Ovaries
D010386 Pelvic Neoplasms Tumors or cancer of the pelvic region. Cancer of Pelvis,Pelvic Cancer,Cancer of the Pelvis,Neoplasms of Pelvis,Pelvis Cancer,Pelvis Neoplasms,Cancer, Pelvic,Cancer, Pelvis,Cancers, Pelvic,Cancers, Pelvis,Neoplasm, Pelvic,Neoplasm, Pelvis,Neoplasms, Pelvic,Neoplasms, Pelvis,Pelvic Cancers,Pelvic Neoplasm,Pelvis Cancers,Pelvis Neoplasm
D011245 Pregnadienes Pregnane derivatives containing two double bonds anywhere within the ring structures.
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002064 Buserelin A potent synthetic analog of GONADOTROPIN-RELEASING HORMONE with D-serine substitution at residue 6, glycine10 deletion, and other modifications. Bigonist,Buserelin Acetate,HOE-766,Profact,Receptal,Suprecur,Suprefact,Tiloryth,Acetate, Buserelin,HOE 766,HOE766
D003613 Danazol A synthetic steroid with antigonadotropic and anti-estrogenic activities that acts as an anterior pituitary suppressant by inhibiting the pituitary output of gonadotropins. It possesses some androgenic properties. Danazol has been used in the treatment of endometriosis and some benign breast disorders. Azol,Cyclomen,Danatrol,Danazant,Danazol-Ratiopharm,Danocrine,Danol,Danoval,Ladogal,Norciden,Panacrine,Danazol Ratiopharm
D004715 Endometriosis A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum. Endometrioma,Endometriomas,Endometrioses

Related Publications

W P Dmowski, and E Radwanska, and Z Binor, and I Tummon, and P Pepping
July 1990, Obstetrics and gynecology,
W P Dmowski, and E Radwanska, and Z Binor, and I Tummon, and P Pepping
October 1989, American journal of obstetrics and gynecology,
W P Dmowski, and E Radwanska, and Z Binor, and I Tummon, and P Pepping
December 1988, Clinical obstetrics and gynecology,
W P Dmowski, and E Radwanska, and Z Binor, and I Tummon, and P Pepping
January 1987, Contributions to gynecology and obstetrics,
W P Dmowski, and E Radwanska, and Z Binor, and I Tummon, and P Pepping
December 1986, European journal of obstetrics, gynecology, and reproductive biology,
W P Dmowski, and E Radwanska, and Z Binor, and I Tummon, and P Pepping
May 1992, American journal of obstetrics and gynecology,
W P Dmowski, and E Radwanska, and Z Binor, and I Tummon, and P Pepping
June 1993, Fertility and sterility,
W P Dmowski, and E Radwanska, and Z Binor, and I Tummon, and P Pepping
January 1990, International journal of fertility,
W P Dmowski, and E Radwanska, and Z Binor, and I Tummon, and P Pepping
June 1996, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed,
W P Dmowski, and E Radwanska, and Z Binor, and I Tummon, and P Pepping
November 2003, Clinical cancer research : an official journal of the American Association for Cancer Research,
Copied contents to your clipboard!